TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biomedola AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,053
|
1,182
|
914 |
| Financial expenses |
67
|
0
|
0 |
| Earnings before taxes |
1,528
|
828
|
703 |
| EBITDA |
507
|
790
|
703 |
| Total assets |
6,374
|
5,111
|
4,272 |
| Current assets |
4,124
|
3,133
|
2,426 |
| Current liabilities |
205
|
212
|
140 |
| Equity capital |
5,847
|
4,580
|
3,848 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.7%
|
89.6%
|
90.1% |
| Turnover per employee |
1,053
|
1,182
|
914 |
| Profit as a percentage of turnover |
145.1%
|
70.1%
|
76.9% |
| Return on assets (ROA) |
25.0%
|
16.2%
|
16.5% |
| Current ratio |
2011.7%
|
1477.8%
|
1732.9% |
| Return on equity (ROE) |
26.1%
|
18.1%
|
18.3% |
| Change turnover |
-151
|
204
|
175 |
| Change turnover % |
-13%
|
21%
|
24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.